Clover Health Investments, Corp.
CLOV
$4.60
$0.112.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.40% | -126.74% | -98.91% | 36.18% | 65.16% |
| Total Depreciation and Amortization | 18.08% | -15.77% | 41.98% | -75.32% | -81.75% |
| Total Amortization of Deferred Charges | 25.00% | 25.00% | 25.00% | -- | -- |
| Total Other Non-Cash Items | 0.86% | 23.79% | 58.83% | 482.88% | 8,059.43% |
| Change in Net Operating Assets | 131.87% | 148.23% | -754.97% | -217.74% | 12.71% |
| Cash from Operations | 264.84% | 875.48% | -292.09% | 38.42% | 77.33% |
| Capital Expenditure | -92.44% | -109.26% | -31.30% | -80.25% | -78.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -231.82% | -548.94% | 188.50% | -54.53% | -58.63% |
| Cash from Investing | -247.21% | -3,300.65% | 621.42% | -56.07% | -60.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 74.12% | 45.84% | 101.11% | 671.31% | 3,167.27% |
| Repurchase of Common Stock | 53.07% | 33.56% | -202.24% | -329.62% | -454.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.62% | 35.50% | -207.49% | -322.70% | -438.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.41% | 133.75% | -744.04% | -53.48% | 52.10% |